We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+10.55%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.9B
AUM Growth
+$82.9M
(+0.56%)
Cap. Flow
-$1.22B
Cap. Flow
% of AUM
-8.19%
Top 10 Holdings %
Top 10 Hldgs %
17.88%
Holding
1,150
New
131
Increased
316
Reduced
491
Closed
190
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$108M |
| 2 |
AT&T
T
|
+$102M |
| 3 |
Valero Energy
VLO
|
+$70.6M |
| 4 |
Marathon Petroleum
MPC
|
+$53.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$51.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.1M |
| 2 |
Dell
DELL
|
+$87.8M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$85.7M |
| 4 |
General Motors
GM
|
+$85.2M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Healthcare | 14.02% |
| 3 | Consumer Discretionary | 12.92% |
| 4 | Financials | 11.35% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HSII
351
DELISTED
Heidrick & Struggles
HSII
| $7.63M | 0.05% |
174,398
+69,416
| +66% | +$3.16M |
|
352
Merit Medical Systems
MMSI
$4.82B
| $7.62M | 0.05% |
122,357
-12,516
| -9% | -$839K |
|
|
NGM
353
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $7.59M | 0.05% |
428,426
-29,520
| -6% | -$566K |
|
354
Texas Instruments
TXN
$248B
| $7.54M | 0.05% |
+40,011
| New | +$7.68M |
|
355
United Natural Foods
UNFI
$3.04B
| $7.51M | 0.05% |
152,967
-24,157
| -14% | -$1.17M |
|
356
Aviat Networks
AVNW
$253M
| $7.46M | 0.05% |
232,422
+36,022
| +18% | +$1.13M |
|
|
CSR
357
Centerspace
CSR
$952M
| $7.42M | 0.05% |
66,941
-6,117
| -8% | -$632K |
|
358
Concentrix
CNXC
$1.62B
| $7.42M | 0.05% |
41,539
-21,450
| -34% | -$3.83M |
|
359
Covenant Logistics
CVLG
$1.04B
| $7.39M | 0.05% |
559,578
+248,584
| +80% | +$3.42M |
|
|
EGRX
360
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $7.27M | 0.05% |
142,692
-20,407
| -13% | -$1.06M |
|
361
Atkore
ATKR
$2.41B
| $7.24M | 0.05% |
+65,132
| New | +$6.62M |
|
|
AERI
362
DELISTED
Aerie Pharmaceuticals
AERI
| $7.12M | 0.05% |
1,014,556
+409,917
| +68% | +$4.29M |
|
|
TGH
363
DELISTED
Textainer Group Holdings limited
TGH
| $7.1M | 0.05% |
198,893
-32,012
| -14% | -$1.16M |
|
364
Nabors Industries
NBR
$1.17B
| $7.08M | 0.05% |
87,275
-2,340
| -3% | -$230K |
|
365
Arch Capital
ACGL
$36.5B
| $7.01M | 0.05% |
157,618
+43,943
| +39% | +$1.86M |
|
366
WaFd
WAFD
$2.71B
| $6.83M | 0.05% |
204,745
+75,134
| +58% | +$2.59M |
|
367
MYR Group
MYRG
$5.01B
| $6.71M | 0.04% |
60,676
-73,527
| -55% | -$7.98M |
|
368
Hanmi Financial
HAFC
$935M
| $6.69M | 0.04% |
282,571
-21,595
| -7% | -$482K |
|
369
Bread Financial
BFH
$4.32B
| $6.66M | 0.04% |
+100,089
| New | +$7.4M |
|
370
Visteon
VC
$2.85B
| $6.66M | 0.04% |
59,888
-107,440
| -64% | -$11.9M |
|
|
REVG
371
DELISTED
REV Group
REVG
| $6.65M | 0.04% |
470,231
-24,881
| -5% | -$393K |
|
372
Accuray
ARAY
$27.5M
| $6.63M | 0.04% |
1,389,060
+150,392
| +12% | +$725K |
|
373
Agilysys
AGYS
$3.21B
| $6.62M | 0.04% |
148,953
-52,417
| -26% | -$2.49M |
|
374
JB Hunt Transport Services
JBHT
$25.9B
| $6.62M | 0.04% |
32,376
-6,642
| -17% | -$1.28M |
|
375
James River Group Holdings
JRVR
$219M
| $6.61M | 0.04% |
229,396
+5,603
| +3% | +$174K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2021 Portfolio in Review
As of Q4 2021, Jacobs Levy Equity Management held 1,150 positions worth $14.9B, up 0.56% from $14.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jacobs Levy Equity Management withdrew a net $1.22B in Q4 2021, closing 190 positions and reducing 491 holdings. Its most notable exit was Cerner Corp, an estimated $46M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jacobs Levy Equity Management opened a new position in Booking.com worth $109M.
- Jacobs Levy Equity Management's largest Q4 2021 buy was Booking.com: 1,135,900 shares worth $109M.
- Jacobs Levy Equity Management added most to AT&T in Q4 2021, an estimated $102M increase.
- Jacobs Levy Equity Management's biggest Q4 2021 reduction was Microsoft, cutting an estimated $89.1M.
- Jacobs Levy Equity Management fully exited Cerner Corp in Q4 2021, selling an estimated $46M.
- Jacobs Levy Equity Management's ten largest holdings make up 18% of its $14.9B portfolio in Q4 2021.
- Jacobs Levy Equity Management opened 131 new positions and closed 190 in Q4 2021.
- Jacobs Levy Equity Management's portfolio value rose 0.56% quarter-over-quarter to $14.9B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2021, filed 14 Feb 2022.